Michael McGrail

Cooley advised HyperBranch, a developer of biosurgical devices, in its sale to Stryker for $220 million.

Cooley advised Image Stream Medical, a developer of visualization and image management solutions, in its sale to Olympus for $87 million.

Cooley advised SuppreMol GmbH, a German developer of therapeutics for the treatment of autoimmune diseases and allergic diseases, in its sale to Baxter International for $230 million. 

Cooley advised TYRX, a developer of implantable combination antibiotic drug and implanted medical devices, in its sale to Medtronic for $160 million. The acquisition helped Medtronic expand its medical device product offerings to include broader healthcare services and solutions.

Cooley represented BASF, one of the world's largest chemical companies, in its $1.02 billion acquisition of Becker Underwood. BASF has more than 370 manufacturing facilities and does business worldwide through six business segments that include plastics, performance products, chemicals, oil and gas exploration and production, functional solutions and agricultural products.